Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biofluid Biopsies and Companion Diagnostics 2014

Biofluid Biopsies and Companion Diagnostics 2014

Monday, 27 October 2014 - Tuesday, 28 October 2014


Keynote Speakers

Scott Patterson

Scott Patterson
Executive Director, Amgen Inc

Nicholas Dracopoli

Nicholas Dracopoli
Vice President/Head, Johnson & Johnson

Klaus Pantel

Klaus Pantel
Professor/Founding Director, University of Hamburg

Oscar Puig

Oscar Puig
Biomarker Leader, Hoffmann La Roche

Ruth Katz

Ruth Katz
Professor, University of Texas MD Anderson Cancer Center

David Hoon

David Hoon
Director/Chief, John Wayne Cancer Institute

Michael Heller

Michael Heller
Professor, University of California San Diego

Martin Siaw

Martin Siaw
Associate Scientific Director, Quest Diagnostics Nichols Institute

Yoshiya Oda

Yoshiya Oda
President, Eisai Inc

Walter Koch

Walter Koch
Vice President, Roche Molecular Systems

Robert Wassman

Robert Wassman
Chief Medical Officer, Rosetta Genomics

View all Keynote Speakers
Biofluid Biopsies and Companion Diagnostics 2014 brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.

The Biofluid Biopsies Conference Track focuses primarily on blood-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.  There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

Major theme of this conference track is to explore the potential of various circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for Biofluid-based Biopsies and Patient Monitoring.

The Companion Diagnostics Conference Track brings together presenters from around the world to offer a comprehensive picture from research, commercial, and regulatory perspectives as to the deployment of biomarkers for precision medicine, and technical as well as economic and regulatory considerations in the development of companion diagnostics for the different cancer sub-classes as well as other disease areas.


Corporate Sponsors Media Sponsors Networking
U-Networks



    Keep me updated Select Bio Blog Linked in Twitter SBOnDemand.com Technology Networks LabTube.tv ePosters